Edwards Lifesciences Corp (EW) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Of the 6 companies Edwards Lifesciences Corp moves with most closely, 1 also shares its SEC classification.
Measured against 499 trading days of our own closes. Co-movement, not cause.
SIC 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies, from each company's own filings. Largest first.
A rule beside a ticker marks a company that appears in both readings.
Which of these the filings never mention ›the bull case· 2
+0.08%
change in shares held by the ten largest reporting managers over the latest quarter
13fJun 30 '261,334
managers reporting a position in the latest quarterly filings
13fJun 30 '26the bear case· 2
7 of 8
recent reports where the move came in under the options-implied range
earnings historyimplied vs realized9 of 20
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Nov 2 '26 report. Not a forecast, not advice.
High 88.49 at 2:45 pm ET, low 87.84 at 11:45 am ET.
Edwards Lifesciences Corp
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
NYSE · Orthopedic, Prosthetic & Surgical Appliances & Supplies
1,337 managers report a position worth $47.2B between them, and 55 of them hold 80% of it.
tall tick = annual report · 1 on record
EW (Edwards Lifesciences Corp) has 0 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.